Abstract
Aspirin makes up the first-line treatment for patients with coronary artery disease. Nevertheless, some recent studies have suggested that the response to regular use of aspirin is not uniform in patients with chronic coronary artery disease, and still little studied in the setting of acute coronary syndromes. However, the lack of standardization and variability of platelet aggregation te…